Passage Bio, Inc., a genetic medicines company, develops gene therapies for central nervous system diseases. It develops PBGM01, a functional GLB1 gene encoding ß-galactosidase for infantile GM1; ...
This story appears in the January 2017 issue of National Geographic magazine. Shadrack Nyongesa’s appointment with the knife was set for shortly after dawn. Since the previous morning, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback